CSIMarket
 


Hologic Inc  (HOLX)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

HOLX's EPS from Cont. Operations Growth by Quarter and Year

Hologic Inc's EPS from Cont. Operations results by quarter and year




HOLX EPS from Cont. Operations (in $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter September - 0.37 0.47 1.30
III Quarter June - -0.16 0.91 1.05
II Quarter March - 0.88 1.81 2.40
I Quarter December 1.03 0.76 1.97 2.53
FY   1.03 1.85 5.16 7.28



HOLX EPS from Cont. Operations first quarter 2024 Y/Y Growth Comment
Hologic Inc reported EPS from Cont. Operations improvement of 35.53% year on year in the first quarter 2024, to $ 1.03 , this is lower than Hologic Inc's recent average EPS from Cont. Operations surge of 126.78%.

According to the results reported in the first quarter 2024, Hologic Inc achieved the best EPS from Cont. Operations growth in Medical Laboratories industry. While Hologic Inc' s EPS from Cont. Operations rise of 35.53% ranks overall at the positon no. 122 in the first quarter 2024.




HOLX EPS from Cont. Operations ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter September - -21.28 % -63.85 % -32.29 %
III Quarter June - - -13.33 % 98.11 %
II Quarter March - -51.38 % -24.58 % 548.65 %
I Quarter December 35.53 % -61.42 % -22.13 % 75.69 %
FY   - -64.15 % -29.12 % 70.89 %

Financial Statements
Hologic Inc's first quarter 2024 EPS from Cont. Operations $ 1.03 HOLX's Income Statement
Hologic Inc's first quarter 2023 EPS from Cont. Operations $ 0.76 Quarterly HOLX's Income Statement
New: More HOLX's historic EPS from Cont. Operations Growth >>


HOLX EPS from Cont. Operations (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter September - - -48.35 % 23.81 %
III Quarter June - - -49.72 % -56.25 %
II Quarter March - 15.79 % -8.12 % -5.14 %
I Quarter December 178.38 % 61.7 % 51.54 % 31.77 %
FY (Year on Year)   - -64.15 % -29.12 % 70.89 %




EPS from Cont. Operations first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #0
Healthcare Sector #5
Overall #122

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
1567.17 % 126.78 % -139.03 %
(Dec 26 2020)   (Dec 29 2018)
EPS from Cont. Operations first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #0
Healthcare Sector #5
Overall #122
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
1567.17 % 126.78 % -139.03 %
(Dec 26 2020)   (Dec 29 2018)

EPS from Cont. Operations by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Hologic Inc's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
506.45 % 49.58 % -100 %
(Apr 01 2017)  


HOLX's I. Quarter Q/Q EPS from Cont. Operations Comment
Hologic Inc achieved in the I. Quarter 2024 above company average sequential EPS from Cont. Operations doubling of 178.38%, to $ 1.03 , from $0.37 in the fourth quarter.
HOLX is going from strength to strength, not only claiming higher then regular growth, and additionally increasing speed.

Within Medical Laboratories industry Hologic Inc achieved highest sequential EPS from Cont. Operations growth. While Hologic Inc's EPS from Cont. Operations growth quarter on quarter, overall rank is 20.


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #1
Healthcare Sector #1
Overall #20
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #1
Healthcare Sector #1
Overall #20
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
506.45 % 49.58 % -100 %
(Apr 01 2017)  


HOLX's I. Quarter Q/Q EPS from Cont. Operations Comment
Hologic Inc achieved in the I. Quarter 2024 above company average sequential EPS from Cont. Operations doubling of 178.38%, to $ 1.03 , from $0.37 in the fourth quarter.
Hologic Inc is impressively improving, with reporting above average growth, and also accelerating speed, Robert  Wilson, a business veteran allocated in Houston mentioned.

Within Medical Laboratories industry Hologic Inc achieved highest sequential EPS from Cont. Operations growth. While Hologic Inc's EPS from Cont. Operations growth quarter on quarter, overall rank is 20.


Hologic Inc's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Dec 30 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jul 01 2023)
12 Months Ending
(Apr 01 2023)
12 Months Ending
(Dec 31 2022)
Cumulative EPS from Cont. Operations 12 Months Ending $ 2.12 $ 1.85 $ 1.95 $ 3.02 $ 3.95
Y / Y EPS from Cont. Operations Growth (TTM) -46.4 % -64.18 % -67.36 % -50.64 % -41.13 %
Year on Year EPS from Cont. Operations Growth Overall Ranking # 137 # 1333 # 1187 # 1254 # 249
Seqeuential EPS from Cont. Operations Change (TTM) 14.6 % -5.36 % -35.38 % -23.52 % -23.43 %
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # 122 # 1117 # 875 # 1134 # 971




Cumulative EPS from Cont. Operations growth Comment
Hologic Inc showed decline, but improvement compare to trailing twelve month EPS from Cont. Operations decrease in Sep 30 2023. If the fiscal year would end in Dec 30 2023, Hologic Inc's annual EPS from Cont. Operations fall would be -46.4% year on year to $2 .

Among companies within the Healthcare sector 4 other companies have achieved higher trailing twelve month EPS from Cont. Operations growth. While Total ranking has impoved so far to 137, from total ranking in previous quarter at 1333.

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
1567.17 %
126.78 %
-139.03 %
 

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 0
Healthcare Sector # 5
Overall # 137

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
1567.17 %
126.78 %
-139.03 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 0
Sector # 5
S&P 500 # 122
Cumulative EPS from Cont. Operations growth Comment
Hologic Inc showed decline, but improvement compare to trailing twelve month EPS from Cont. Operations decrease in Sep 30 2023. If the fiscal year would end in Dec 30 2023, Hologic Inc's annual EPS from Cont. Operations drop would be -46.4% year on year to $2 .

Among companies within the Healthcare sector 4 other companies have achieved higher trailing twelve month EPS from Cont. Operations growth. While Total ranking has impoved so far to 137, from total ranking in previous quarter at 1333.

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
1567.17 %
126.78 %
-139.03 %
 


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 0
Healthcare Sector # 5
Overall # 137

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
1567.17 %
126.78 %
-139.03 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 0
Sector # 5
S&P 500 # 122




Other EPS from Cont. Operations Growth
Medical Laboratories Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
HOLX's EPS from Cont. Operations Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for HOLX's Competitors
EPS from Cont. Operations Growth for Hologic Inc's Suppliers
EPS from Cont. Operations Growth for HOLX's Customers

You may also want to know
HOLX's Annual Growth Rates HOLX's Profitability Ratios HOLX's Asset Turnover Ratio HOLX's Dividend Growth
HOLX's Roe HOLX's Valuation Ratios HOLX's Financial Strength Ratios HOLX's Dividend Payout Ratio
HOLX's Roa HOLX's Inventory Turnover Ratio HOLX's Growth Rates HOLX's Dividend Comparisons



Companies with similar EPS from Cont. Operations drop for the quarter ending Dec 30 2023 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Dec 30 2023
United Therapeutics Corporation60.16%$ 60.158 
Cytek Biosciences Inc 57.66%$ 57.659 
Abbott Laboratories55.26%$ 55.256 
Halozyme Therapeutics Inc 55.17%$ 55.172 
Tactile Systems Technology Inc 52.10%$ 52.101 
Lemaitre Vascular Inc 48.69%$ 48.693 
Msa Safety Incorporated46.19%$ 46.189 
Integer Holdings Corporation44.60%$ 44.597 
Chemed Corporation43.12%$ 43.119 
Healthcare Services Group Inc 40.85%$ 40.848 
Viemed Healthcare Inc 40.75%$ 40.751 
Ufp Technologies Inc 36.08%$ 36.083 
Hologic Inc35.53%$ 35.526 
Catalyst Pharmaceuticals Inc 34.07%$ 34.071 
West Pharmaceutical Services Inc 33.63%$ 33.631 
National Research Corporation33.56%$ 33.559 
Cadre Holdings Inc 30.00%$ 30.000 
Novartis Ag29.47%$ 29.467 
Semler Scientific Inc 29.02%$ 29.016 
Orasure Technologies Inc27.60%$ 27.603 
Option Care Health Inc 24.37%$ 24.371 
The Pennant Group Inc 24.20%$ 24.202 
Conmed Corporation23.15%$ 23.147 
Inmode Ltd 20.92%$ 20.918 
Icon Plc20.32%$ 20.323 
Vertex Pharmaceuticals Inc17.94%$ 17.938 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com